1-(4-((6-(Propylamino)pyrimidin-4-yl)oxy)phenyl)-3-(3-(trifluoromethyl)phenyl)urea

ID: ALA4877505

PubChem CID: 164628024

Max Phase: Preclinical

Molecular Formula: C21H20F3N5O2

Molecular Weight: 431.42

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  CCCNc1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ncn1

Standard InChI:  InChI=1S/C21H20F3N5O2/c1-2-10-25-18-12-19(27-13-26-18)31-17-8-6-15(7-9-17)28-20(30)29-16-5-3-4-14(11-16)21(22,23)24/h3-9,11-13H,2,10H2,1H3,(H,25,26,27)(H2,28,29,30)

Standard InChI Key:  KICQFMWQIMWJTM-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 31 33  0  0  0  0  0  0  0  0999 V2000
   38.9363   -2.0801    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   38.5318   -2.7900    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.3488   -2.7853    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   29.3349   -1.6055    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.3338   -2.4250    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.7487   -1.6019    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.0400   -1.1966    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.4548   -1.1906    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   32.1641   -1.5965    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.1638   -2.4114    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.8722   -2.8172    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.5794   -2.4059    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.5736   -1.5845    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.8647   -1.1824    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.2891   -2.8109    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.9948   -2.3987    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.7045   -2.8037    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.9906   -1.5815    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   36.4102   -2.3915    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.1180   -2.7983    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.8232   -2.3868    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.8195   -1.5687    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.1047   -1.1639    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.4025   -1.5778    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.5365   -3.6093    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   30.7560   -2.4242    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.0410   -2.8318    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.0394   -3.6490    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.3309   -4.0562    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.6240   -3.6462    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.9155   -4.0534    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  4  5  2  0
  5 27  1  0
 26  6  1  0
  6  7  2  0
  7  4  1  0
  6  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  9  1  0
 12 15  1  0
 15 16  1  0
 16 17  1  0
 16 18  2  0
 17 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 19  1  0
 21  2  1  0
  2 25  1  0
 26 27  2  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA4877505

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 431.42

Molecular Weight (Monoisotopic): 431.1569

AlogP: 5.75

#Rotatable Bonds: 7

Polar Surface Area: 88.17

Molecular Species: NEUTRAL

HBA: 5

HBD: 3

#RO5 Violations: 1

HBA (Lipinski): 7

HBD (Lipinski): 3

#RO5 Violations (Lipinski): 1

CX Acidic pKa: 11.53

CX Basic pKa: 4.76

CX LogP: 5.11

CX LogD: 5.11

Aromatic Rings: 3

Heavy Atoms: 31

QED Weighted: 0.44

Np Likeness Score: -1.70

References

1. Patterson JR, Graves AP, Stoy P, Cheung M, Desai TA, Fries H, Gatto GJ, Holt DA, Shewchuk L, Totoritis R, Wang L, Kallander LS..  (2021)  Identification of Diarylurea Inhibitors of the Cardiac-Specific Kinase TNNI3K by Designing Selectivity Against VEGFR2, p38α, and B-Raf.,  64  (21.0): [PMID:34699203] [10.1021/acs.jmedchem.1c00700]

Source

Source(1):

• Scientific Literature